Summary
Ambrx Inc (Ambrx) focuses on the discovery and development of protein-based medicines. The company’s pipeline product candidate’s portfolio includes ARX618 FGF21, PSMA ADC, CD70 ADC and Anti-CD3 X Folate. It develops pipeline candidates for various therapeutic indications such as diabetes, oncology and heart failure. Ambrx utilizes its Protein Medicinal Chemistry process, which combines site specific conjugation with proprietary linkers, payloads and pharmacokinetic extenders to create a single molecular species. The company works in collaboration with other pharmaceutical and biotechnology companies to discover and develop novel drug candidates for other therapeutic indications. Ambrx is headquartered in La Jolla, California, the US.
Ambrx Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Ambrx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Ambrx Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Ambrx Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Ambrx Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Ambrx Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Ambrx Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Ambrx Raises USD45 Million in Venture Financing 10
Partnerships 11
Ambrx Enters into Agreement with MabSpace Biosciences 11
Zhejiang Hisun Pharma to Enter Co-Development Agreement with Ambrx 12
Ambrx Enters Into Agreement With Zhejiang Medicine To Develop Antibody Drug Conjugate For Breast Cancer 12
Ambrx Enters Into Co-Development Agreement With Bristol-Myers Squibb 14
Astellas Pharma Enters Into Co-Development Agreement With Ambrx 15
Bristol-Myers Squibb Enters Into Co-Development Agreement With Ambrx 16
Licensing Agreements 17
Ambrx Enters Into Licensing Agreement With Merck For Site Specific Protein Medicinal Chemistry Technology 17
Equity Offering 18
Ambrx Withdraws Registration Statement for IPO of Shares 18
Acquisition 19
Shanghai Fosun Pharma, HOPU Investments, CEL Healthcare Fund and WuXi PharmaTech to Acquire Ambrx 19
Ambrx Inc - Key Competitors 21
Key Employees 22
Locations And Subsidiaries 23
Head Office 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24
List of Tables
Ambrx Inc, Pharmaceuticals & Healthcare, Key Facts 1
Ambrx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Ambrx Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Ambrx Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Ambrx Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Ambrx Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Ambrx Raises USD45 Million in Venture Financing 10
Ambrx Enters into Agreement with MabSpace Biosciences 11
Zhejiang Hisun Pharma to Enter Co-Development Agreement with Ambrx 12
Ambrx Enters Into Agreement With Zhejiang Medicine To Develop Antibody Drug Conjugate For Breast Cancer 12
Ambrx Enters Into Co-Development Agreement With Bristol-Myers Squibb 14
Astellas Pharma Enters Into Co-Development Agreement With Ambrx 15
Bristol-Myers Squibb Enters Into Co-Development Agreement With Ambrx 16
Ambrx Enters Into Licensing Agreement With Merck For Site Specific Protein Medicinal Chemistry Technology 17
Ambrx Withdraws Registration Statement for IPO of Shares 18
Shanghai Fosun Pharma, HOPU Investments, CEL Healthcare Fund and WuXi PharmaTech to Acquire Ambrx 19
Ambrx Inc, Key Competitors 21
Ambrx Inc, Key Employees 22
List of Figures
Ambrx Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Ambrx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Ambrx Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Ambrx Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Ambrx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Ambrx Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Ambrx Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Ambrx Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8